GLP-1 Drugs Might Cut Dementia Risk in Half

GLP-1 Drugs Might Cut Dementia Risk in Half

Source: Medscape

New evidence brings more good news about the unanticipated effects of the GLP-1 receptor agonists.

This transcript has been edited for clarity.
Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson from the Yale School of Medicine.
It’s quite a thing that we live in an era with the biggest blockbus… [7596 chars]

Read more